Menstrual Disorders are conditions in which menstrual bleeding patterns, cycle timing, associated pain or other menstruation-related features are sufficiently abnormal or burdensome to warrant clinical attention. The term is broad and can encompass excessive or prolonged bleeding, irregular cycles, absent menstruation, unusually painful periods and other disturbances, although specific classification systems use different terminology. A menstrual pattern that differs from an individual's previous experience is not automatically a disorder because normal variation is considerable across age and reproductive stage. Clinical assessment considers severity, duration, frequency, impact on daily life and possible underlying causes. Menstrual Disorders can result from hormonal disturbances, structural uterine conditions, pregnancy-related causes, medications, systemic illness, bleeding disorders and disorders affecting the ovaries or reproductive tract.
Abnormal uterine bleeding is an important component of Menstrual Disorders and can be described according to the timing, regularity, duration and volume of bleeding. Heavy menstrual bleeding refers to bleeding that is excessive enough to affect physical, social, emotional or material quality of life, rather than relying exclusively on an exact volume measurement because people generally cannot measure menstrual blood loss accurately at home.
Causes can include structural abnormalities within the uterus and non-structural causes such as ovulatory dysfunction, coagulation disorders, endometrial problems and medication effects. The FIGO PALM-COEIN framework is one internationally used classification approach for causes of abnormal uterine bleeding, separating structural categories from non-structural categories. This illustrates why “heavy periods” is a symptom description rather than a complete diagnosis.
Painful menstruation, or dysmenorrhoea, is another common manifestation. Primary dysmenorrhoea occurs without an identifiable pelvic disease and is strongly associated with increased prostaglandin production and uterine contractions. Secondary dysmenorrhoea results from an underlying pelvic condition and becomes particularly important when pain is new, progressively worsening, unusually severe or accompanied by other symptoms. Endometriosis and Adenomyosis are notable causes, while other pelvic disorders can also contribute.
Pain should be evaluated according to its functional impact, associated symptoms and clinical pattern rather than judged solely by whether it occurs during menstruation. Persistent severe pain can interfere with education, employment, relationships, sleep and physical activity, making effective assessment and treatment an important component of Menstrual Health.
Absent menstruation is called amenorrhoea and may be primary or secondary depending on the individual's developmental and menstrual history. Secondary amenorrhoea can result from pregnancy, lactation, changes in energy availability, intense exercise, endocrine disorders, ovarian dysfunction, medications and other causes. Irregular or infrequent menstruation can occur when Ovulation is inconsistent or absent, as commonly occurs in Polycystic Ovary Syndrome. Conversely, frequent or unpredictable bleeding can arise from hormonal instability, structural lesions or other medical conditions. Menstrual patterns can also be deliberately altered by hormonal contraception, so absence or irregularity does not necessarily indicate disease. Assessment must therefore consider reproductive context, contraceptive use, age, pregnancy possibility and previous cycle pattern before interpreting the abnormality.
Diagnosis of Menstrual Disorders begins with a detailed history covering cycle length, bleeding duration, perceived heaviness, pain, intermenstrual bleeding, post-coital bleeding, medication use and reproductive history. Symptoms such as fatigue, dizziness or breathlessness may suggest anaemia in someone with heavy bleeding. Pregnancy testing is important when clinically relevant, and blood tests can assess haemoglobin, iron status, thyroid function or other factors depending on the presentation.
Pelvic ultrasound is commonly used to identify structural causes, while further imaging or procedures may be appropriate in selected cases. A bleeding disorder may need consideration when heavy bleeding has been present since the earliest menstrual periods or is accompanied by easy bruising or other bleeding symptoms. Investigation should be targeted rather than automatically extensive because the causes and appropriate tests differ markedly between individuals.
Treatment varies according to the type and cause of the Menstrual Disorder and whether fertility is desired. Heavy bleeding may be treated with anti-inflammatory medicines, antifibrinolytic medication, hormonal therapy or treatment of a structural cause, while some people require procedural or surgical intervention. Iron deficiency should be recognised and treated where present. Primary dysmenorrhoea often responds to non-steroidal anti-inflammatory medicines because they reduce prostaglandin production, and hormonal contraception can reduce ovulation and endometrial activity in suitable patients. Secondary pain requires treatment directed towards the underlying disorder. Management should consider age, contraindications, reproductive goals, symptom severity and personal preferences. A treatment that reduces bleeding may be inappropriate or unnecessary for someone whose principal problem is pain, illustrating why precise symptom classification matters.
Menstrual Disorders have historically been under-recognised in part because significant menstrual pain and heavy bleeding have sometimes been treated as inevitable aspects of being menstruating. Modern approaches increasingly emphasise quality of life and the identification of underlying disease. Terminology has also evolved, with some older labels being replaced by more precise descriptions based on bleeding pattern or cause. Research into menstrual disorders intersects with reproductive endocrinology, gynaecology, haematology and public health.
Epidemiological estimates vary because definitions and measurement methods differ, but menstrual symptoms are sufficiently common to represent a major healthcare issue. At the same time, overdiagnosis is possible if normal physiological variation is treated as pathology. Good clinical practice therefore requires distinguishing expected variation from symptoms that are persistent, severe, changing or associated with evidence of disease.
A common misconception is that all menstrual irregularity means hormonal imbalance or that heavy bleeding can be judged accurately from the number of products used alone. Product use varies greatly between individuals, so clinical definitions emphasise impact and associated findings rather than an exact household measurement. Another misconception is that severe menstrual pain is simply something that must be endured. While some dysmenorrhoea is common, severe or progressively worsening pain can indicate underlying pathology.
Menstrual Disorders are also not a single disease; the term covers multiple patterns and causes with different treatments. Their clinical significance comes from both direct symptoms and secondary consequences such as iron deficiency, impaired daily functioning, delayed diagnosis of underlying disease and reduced quality of life.
